Wheetai Kim, Ph.D. - Publications

Affiliations: 
2001 University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Early Childhood Education, Individual and Family Studies, Speech Communication

252 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Choi DK, Kim YK, Park SW, Lee H, Lee S, Kim SA, Kim SJ, Lee J, Kim W, Min SH, Yu JH. The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells. Scientific Reports. 10: 12089. PMID 32694555 DOI: 10.1038/s41598-020-69103-x  0.8
2020 Jang WY, Kang DO, Park Y, Lee J, Kim W, Choi JY, Roh SY, Jang Y, Park SH, Kim WS, Na JO, Choi CU, Rha SW, Park CG, Seo HS, et al. Validation of FRIEND and ACSM Equations for Cardiorespiratory Fitness: Comparison to Direct Measurement in CAD Patients. Journal of Clinical Medicine. 9. PMID 32560313 DOI: 10.3390/jcm9061889  0.36
2020 Yoon SE, Kim SJ, Yoon DH, Koh Y, Mun YC, Do YR, Choi YS, Yang DH, Kim MK, Lee GW, Suh C, Ko YH, Kim WS. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis. Annals of Hematology. PMID 32333154 DOI: 10.1007/s00277-020-04005-6  0.8
2020 Yoon DH, Cao J, Chen TY, Izutsu K, Kim SJ, Kwong YL, Lin TY, Thye LS, Xu B, Yang DH, Kim WS. Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group. Journal of Hematology & Oncology. 13: 21. PMID 32183871 DOI: 10.1186/s13045-020-00855-9  0.8
2020 Kim YT, Kim WJ, Choi JE, Bae MJ, Jang H, Lee CJ, Lee HJ, Im DJ, Ye BS, Kim MJ, Jeong Y, Oh SS, Jung YC, Kang ES, Park S, et al. Cohort Profile: Firefighter Research on the Enhancement of Safety and Health (FRESH), a Prospective Cohort Study on Korean Firefighters. Yonsei Medical Journal. 61: 103-109. PMID 31887807 DOI: 10.3349/ymj.2020.61.1.103  0.32
2019 Kim S, Lee JS, Kim W, Kim YH, Kim JS, Lim SY, Kim SH, Ahn JC, Park CG, Song WH. Central hemodynamic characteristics of young adults with isolated systolic hypertension: an ambulatory blood pressure monitoring-based study of real-world clinical patients. Hypertension Research : Official Journal of the Japanese Society of Hypertension. PMID 31811243 DOI: 10.1038/s41440-019-0352-1  0.36
2019 Cho YD, Kim BS, Kim WJ, Kim HJ, Baek JH, Woo KM, Seol YJ, Ku Y, Ryoo HM. Histone acetylation together with DNA demethylation empowers higher plasticity in adipocytes to differentiate into osteoblasts. Gene. 144274. PMID 31809844 DOI: 10.1016/j.gene.2019.144274  0.36
2019 Kim SJ, Kang D, Kim I, Yoon SE, Kim WS, Butow PN, Guallar E, Cho J. Impact of fear of cancer recurrence on survival among lymphoma patients. Psycho-Oncology. PMID 31654534 DOI: 10.1002/pon.5265  0.8
2019 Cho J, Kim SJ, Park WY, Kim J, Woo J, Kim G, Yoon SE, Ko YH, Kim WS. Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31653980 DOI: 10.1038/s41379-019-0392-8  0.8
2019 Tan KM, Chia B, Lim JQ, Khoo LP, Cheng CL, Tan L, Poon E, Somasundaram N, Farid M, Tang TPL, Tao M, Cheah DMZ, Laurensia Y, Pang JWL, Song T, ... ... Kim WS, et al. A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study. Scientific Reports. 9: 14961. PMID 31628410 DOI: 10.1038/s41598-019-51522-0  0.8
2019 Oh SY, Kim WS, Kim JS, Kim SJ, Yoon DH, Yang DH, Lee WS, Kim HJ, Yhim HY, Jeong SH, Won JH, Lee S, Kong JH, Lim SN, Ji JH, et al. Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study. Cancer Communications (London, England). 39: 58. PMID 31619290 DOI: 10.1186/s40880-019-0403-7  0.8
2019 Yi JH, Lee GW, Do YR, Jung HR, Hong JY, Yoon DH, Suh C, Choi YS, Yi SY, Sohn BS, Kim BS, Oh SY, Park J, Jo JC, Lee SS, ... ... Kim WS, et al. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma. Annals of Hematology. PMID 31493002 DOI: 10.1007/s00277-019-03791-y  0.8
2019 Kim SJ, Yoon DH, Kim JS, Kang HJ, Lee HW, Eom HS, Hong JY, Cho J, Ko YH, Huh J, Yang WI, Park WS, Lee SS, Suh C, Kim WS. Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31476851 DOI: 10.4143/crt.2019.198  0.8
2019 Kim WH, Jung YE, Roh D, Kim D, Kang SH, Chae JH, Park JE. Reliability and Validity of the Korean Version of Clinician-Administered Posttraumatic Stress Disorder Scale for DSM-5. Journal of Korean Medical Science. 34: e219. PMID 31432652 DOI: 10.3346/jkms.2019.34.e219  0.32
2019 Huh SJ, Oh SY, Lee S, Lee JH, Kim SH, Lee GW, Kim SJ, Kim WS, Lee HS, Jo JC, Kim MJ, Kwon JH, Kim HJ. The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores. International Journal of Hematology. PMID 31250282 DOI: 10.1007/s12185-019-02693-z  0.8
2019 Park BB, Kim WS, Suh C, Hong JY, Yang DH, Lee WS, Do YR, Koh YI, Won JH, Kim MK, Jo JC, Hyun SY, Kim JA, Oh YH, Lee SS. A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & Lymphoma. 1-7. PMID 31170847 DOI: 10.1080/10428194.2019.1622100  0.4
2019 Lee WY, Suh DI, Song DJ, Baek HS, Shin M, Yoo Y, Kwon JW, Jang GC, Yang HJ, Lee E, Seo JH, Woo SI, Kim HY, Shin YH, Lee JS, ... ... Kim WK, et al. Asthma control test reflects not only lung function but also airway inflammation in children with stable asthma. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 1-6. PMID 30969134 DOI: 10.1080/02770903.2019.1599386  0.36
2019 Shin SH, Kim YJ, Lee D, Cho D, Ko YH, Cho J, Park WY, Park D, Kim SJ, Kim WS. Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes. Leukemia & Lymphoma. 1-10. PMID 30774000 DOI: 10.1080/10428194.2019.1573998  0.8
2019 Shin J, Ko YH, Oh SY, Yoon DH, Lee JO, Kim JS, Park Y, Shin HJ, Kim SJ, Won JH, Yoon SS, Kim WS, Koh Y. Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30764603 DOI: 10.4143/crt.2018.555  0.8
2018 Kim DY, Jeong ID, Kim JH, Kim HY, Kim WC. Reproducibility of different coping arrangements fabricated by dental micro-stereolithography: Evaluation of marginal and internal gaps in metal copings. Journal of Dental Sciences. 13: 220-225. PMID 30895124 DOI: 10.1016/j.jds.2017.06.006  0.36
2018 Park S, Jo JC, Do YR, Yang DH, Lim SN, Lee WS, Kim WS, Lee HS, Hong DS, Kim HJ, Shin HJ. Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia. PMID 30581162 DOI: 10.1016/j.clml.2018.11.003  0.36
2018 Jung H, Oh IK, Yoon CM, Park BE, Lee S, Kwon O, Lee WJ, Kwon SH, Kim WH, Kim H. Effects of Ar Addition to O Plasma on Plasma-Enhanced Atomic Layer Deposition of Oxide Thin Films. Acs Applied Materials & Interfaces. PMID 30358984 DOI: 10.1021/acsami.8b14244  0.36
2018 Park S, Kim D, Park S, Kim S, Lee D, Kim W, Kim J. Nanopatterned Scaffolds for Neural Tissue Engineering and Regenerative Medicine. Advances in Experimental Medicine and Biology. 1078: 421-443. PMID 30357636 DOI: 10.1007/978-981-13-0950-2_22  0.32
2018 Kim SJ, Shu C, Ryu KJ, Kang D, Cho J, Ko YH, Lee SY, Guallar E, Zhao W, Kim WS. Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma. Cancer Science. PMID 30343526 DOI: 10.1111/cas.13844  0.8
2018 Yi JH, Ryu KJ, Ko YH, Kim WS, Kim SJ. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma. Cytokine. PMID 30327172 DOI: 10.1016/j.cyto.2018.10.009  0.8
2018 Hong J, Cho J, Ko YH, Kim SJ, Kim WS. Validation of the Marginal Zone Lymphoma International Prognostic Index. Annals of Hematology. PMID 30310985 DOI: 10.1007/s00277-018-3516-1  0.8
2018 Tak YJ, Hilt F, Keene ST, Kim WG, Dauskardt RH, Salleo A, Kim HJ. High-throughput open-air plasma activation of metal-oxide thin films with low thermal budget. Acs Applied Materials & Interfaces. PMID 30288973 DOI: 10.1021/acsami.8b12373  0.36
2018 Park MH, Subbiah R, Kwon MJ, Kim WJ, Kim SH, Park K, Lee K. The three dimensional cues-integrated-biomaterial potentiates differentiation of human mesenchymal stem cells. Carbohydrate Polymers. 202: 488-496. PMID 30287027 DOI: 10.1016/j.carbpol.2018.09.010  0.36
2018 Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, ... ... Kim WS, et al. Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30221329 DOI: 10.1007/s00259-018-4163-4  0.8
2018 Choi JY, Choi CU, Hwang SY, Choi BG, Jang WY, Kim DY, Kim W, Park EJ, Lee S, Na JO, Kim JW, Kim EJ, Rha SW, Park CG, Seo HS, et al. Effect of Pitavastatin Compared with Atorvastatin and Rosuvastatin on New-Onset Diabetes Mellitus in Patients With Acute Myocardial Infarction. The American Journal of Cardiology. PMID 30217375 DOI: 10.1016/j.amjcard.2018.06.017  0.36
2018 Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, Joung JG, Nam JY, Ryu D, Yun JW, Choi JK, Ghosh A, Kim KK, Kim SJ, Kim WS, et al. Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in followed by mutations in and . Oncotarget. 9: 32882. PMID 30214692 DOI: 10.18632/oncotarget.26080  0.8
2018 Hwang HS, Yoon DH, Hong JY, Park CS, Lee YS, Ko YH, Kim SJ, Kim WS, Suh C, Huh J. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms. Annals of Hematology. PMID 30069703 DOI: 10.1007/s00277-018-3442-2  0.8
2018 Jeong SH, Song HN, Park JS, Yang DH, Koh Y, Yoon SS, Lee HW, Eom HS, Won JH, Kim WS, Kim SJ. Allogeneic stem cell transplantation for patients with natural killer/T-cell lymphoid malignancy: a multicenter analysis comparing upfront and salvage transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30064012 DOI: 10.1016/j.bbmt.2018.07.034  0.8
2018 Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, ... ... Kim WS, et al. A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30056546 DOI: 10.1007/s00259-018-4093-1  0.8
2018 Kim SJ, Hyeon J, Cho I, Ko YH, Kim WS. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30025443 DOI: 10.4143/crt.2018.191  0.8
2018 Weon S, Choi E, Kim H, Kim JY, Park HJ, Kim SM, Kim W, Choi W. Active {001} Facet Exposed TiO Nanotubes Photocatalyst Filter for Volatile Organic Compounds Removal: From Material Development to Commercial Indoor Air Cleaner Application. Environmental Science & Technology. PMID 30001490 DOI: 10.1021/acs.est.8b02282  0.32
2018 Lee H, Oh D, Yang K, Ko YH, Ahn YC, Kim WS, Kim SJ. Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29986575 DOI: 10.4143/crt.2018.190  0.8
2018 Oh SY, Kim WS, Kang HJ, Lee JH, Huh SJ, Kim SJ, Yoon DH, Hong JY, Lee WS, Kim HJ, Won JH, Park BB, Lee SI, Suh C. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study. Annals of Hematology. PMID 29947974 DOI: 10.1007/s00277-018-3387-5  0.8
2018 Bach DH, Kim D, Bae SY, Kim WK, Hong JY, Lee HJ, Rajasekaran N, Kwon S, Fan Y, Luu TT, Shin YK, Lee J, Lee SK. Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells. Molecular Therapy. Nucleic Acids. 11: 455-467. PMID 29858080 DOI: 10.1016/j.omtn.2018.03.011  0.4
2018 Kim W, Yoon YE, Shin SH, Bae JW, Hong BK, Hong SJ, Sung KC, Han SH, Kim W, Rhee MY, Kim SH, Lee SE, Hyon MS, Hwang GS, Son JW, et al. Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia. Clinical Therapeutics. PMID 29857919 DOI: 10.1016/j.clinthera.2018.04.015  0.36
2018 Hyeon J, Lee B, Shin SH, Yoo HY, Kim SJ, Kim WS, Park WY, Ko YH. Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29765142 DOI: 10.1038/s41379-018-0064-0  0.8
2018 Choi WG, Rha SW, Choi BG, Choi SY, Byun JK, Mashaly A, Park Y, Jang WY, Kim W, Choi JY, Park EJ, Na JO, Choi CU, Kim EJ, Park CG, et al. The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention. Yonsei Medical Journal. 59: 489-494. PMID 29749131 DOI: 10.3349/ymj.2018.59.4.489  0.36
2018 Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y, Kim WS. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Annals of Hematology. PMID 29627879 DOI: 10.1007/s00277-018-3313-x  0.8
2018 Hong JY, Yoon DH, Suh C, Kim WS, Kim SJ, Jo JC, Kim JS, Lee WS, Oh SY, Park Y, Kim SY, Lee MH, Lee HS, Do YR. Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis. Annals of Hematology. PMID 29619501 DOI: 10.1007/s00277-018-3317-6  0.8
2018 Yamaguchi M, Suzuki R, Kim SJ, Ko YH, Oguchi M, Asano N, Miyazaki K, Terui Y, Kubota N, Maeda T, Kobayashi Y, Amaki J, Soejima T, Saito B, Shimoda E, ... ... Kim WS, et al. Early disease progression in patients with localized NK/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Science. PMID 29601137 DOI: 10.1111/cas.13597  0.8
2018 Cho H, Yoon DH, Kim KP, Bae KS, Kim WS, Eom HS, Kim JS, Hong JY, Kim SJ, Lee H, Kim SJ, Suh C. Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy. Investigational New Drugs. PMID 29520651 DOI: 10.1007/s10637-018-0582-0  0.8
2018 Kim JH, Kim WS, Ryu KJ, Kim SJ, Park C. CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL. Blood Cancer Journal. 8: 23. PMID 29472546 DOI: 10.1038/s41408-018-0056-9  0.8
2018 Kim WH, Lee SW, Kim HJ, Chae YS, Jeong SY, Jung JH, Park HY, Lee WK. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients. Scientific Reports. 8: 3181. PMID 29453385 DOI: 10.1038/s41598-018-21554-z  0.36
2018 Yoo KH, Kang D, Kim IR, Choi EK, Kim JS, Yoon SS, Lee CH, Park S, Kim SJ, Kim K, Kim WS, Jung CW, Choi HJ, Jang JH, Cho J. Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study. Bone Marrow Transplantation. PMID 29403022 DOI: 10.1038/s41409-018-0097-5  0.8
2017 Yun SJ, Kim SK, Kim J, Cha EJ, Kim JS, Kim SJ, Ha YS, Kim YH, Jeong P, Kang HW, Kim JH, Park JL, Choi YK, Moon SK, Choi YH, ... ... Kim WJ, et al. Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer. Oncotarget. 8: 114845-114855. PMID 29383125 DOI: 10.18632/oncotarget.22296  0.8
2017 Yi JH, Kim SJ, Kim WS. Brentuximab vedotin: clinical updates and practical guidance. Blood Research. 52: 243-253. PMID 29333400 DOI: 10.5045/br.2017.52.4.243  0.8
2017 Jang WY, Kim W, Park EJ, Choi JY, Choi CU, Lim HE, Kim JW, Kim EJ, Rha SW, Na JO. Congenital Left Atrial Bands with Atrial Fibrillation. Journal of Cardiovascular Ultrasound. 25: 140-141. PMID 29333222 DOI: 10.4250/jcu.2017.25.4.140  0.36
2017 Yi JH, Kim SJ, Kim WS. Recent advances in understanding and managing T-cell lymphoma. F1000research. 6: 2123. PMID 29259783 DOI: 10.12688/f1000research.12573.1  0.8
2017 Takayama T, Shin S, Kang S, Kim SJ, Kim WS, Ko YH. Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay. Human Pathology. PMID 29258904 DOI: 10.1016/j.humpath.2017.12.006  0.8
2017 Tang T, Khoo LP, Lim C, Ham JS, Kim SJ, Hong H, Phipps C, Lee YS, Tao M, Quek R, Farid M, Lin T, Kim WS, Lim ST. Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers. Blood Cancer Journal. 7: 653. PMID 29242582 DOI: 10.1038/s41408-017-0030-y  0.8
2017 Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, ... ... Kim WS, et al. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma. Oncotarget. 8: 92171-92182. PMID 29190906 DOI: 10.18632/oncotarget.20988  0.8
2017 Kang D, Cho J, Kim I, Kim MK, Kim WS, Kim SJ. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29121713 DOI: 10.4143/crt.2017.207  0.8
2017 Seo J, Kim WS, Kim JS, Kim SJ, Lee JH, Hong JS, Lee GW, Oh SY, Lee JH, Yoon DH, Lee WS, Kim HJ, Kwak JY, Kang HJ, Jo JC, et al. Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial. Blood Research. 52: 200-206. PMID 29043235 DOI: 10.5045/br.2017.52.3.200  0.8
2017 Kim HY, Jang MA, Kim HJ, Kim SJ, Kim WS, Kim SH. Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma. Blood Research. 52: 193-199. PMID 29043234 DOI: 10.5045/br.2017.52.3.193  0.8
2017 Kim W, Park S, Kim K, Kim SJ. Experimental verification of simultaneous desalting and molecular preconcentration by ion concentration polarization. Lab On a Chip. PMID 29022019 DOI: 10.1039/c7lc00857k  0.8
2017 Park JS, Lim DH, Ahn YC, Park W, Kim SJ, Kim WS, Kim K. Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy. Japanese Journal of Clinical Oncology. 1-7. PMID 28973509 DOI: 10.1093/jjco/hyx120  0.8
2017 Kim WS, Kim H, Jeong EM, Kim HJ, Lee ZH, Kim IG, Kim HH. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway. Scientific Reports. 7: 10626. PMID 28878266 DOI: 10.1038/s41598-017-11246-5  0.36
2017 Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. The Korean Journal of Internal Medicine. 32: 890-899. PMID 28870016 DOI: 10.3904/kjim.2015.406  0.8
2017 Lee S, Kim D, Kang J, Kim E, Kim W, Youn H, Youn B. Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 42: 1684-1700. PMID 28743125 DOI: 10.1159/000479418  0.36
2017 Kim H, Choe JH, Choi JH, Kim HJ, Park SH, Lee MW, Kim W, Go GW. Medium-Chain Enriched Diacylglycerol (MCE-DAG) Oil Decreases Body Fat Mass in Mice by Increasing Lipolysis and Thermogenesis in Adipose Tissue. Lipids. PMID 28707153 DOI: 10.1007/s11745-017-4277-7  0.36
2017 Md GI, Oh D, Kim WS, Kim SJ, Ko YH, Woo KI, Kim YD, Ahn YC. Low Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-cell Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28618774 DOI: 10.4143/crt.2017.182  0.8
2017 Kim SH, Ko JH, Park GE, Cho SY, Ha YE, Kang JM, Kim YJ, Huh HJ, Ki CS, Jeong BH, Park J, Jang JH, Kim WS, Kang CI, Chung DR, et al. Atypical presentations of MERS-CoV infection in immunocompromised hosts. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 28545936 DOI: 10.1016/j.jiac.2017.04.004  0.36
2017 Heo MH, Park HY, Ko YH, Kim WS, Kim SJ. IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma. Journal of Cancer. 8: 1018-1024. PMID 28529614 DOI: 10.7150/jca.17358  0.8
2017 Jeon MJ, Kim WG, Kwon H, Kim M, Park S, Oh HS, Han M, Sung TY, Chung KW, Hong SJ, Kim TY, Shong YK, Kim WB. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma. European Journal of Endocrinology. PMID 28432268 DOI: 10.1530/EJE-17-0160  0.32
2017 Cho J, Kang D, Kim IR, Kim WS, Ferrell B, Kim SJ. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28361524 DOI: 10.4143/crt.2017.091  0.8
2017 Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH. Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28361522 DOI: 10.4143/crt.2016.525  0.32
2017 Kim HS, Lee JY, Lim SH, Cho J, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K. Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma. Nutrition (Burbank, Los Angeles County, Calif.). 36: 67-71. PMID 28336110 DOI: 10.1016/j.nut.2016.06.009  0.8
2017 Lee BK, Kim YJ, Ryoo SM, Kim SJ, Lee DH, Jeung KW, Kim WY. "Pseudo-subarachnoid hemorrhage sign" on early brain computed tomography in out-of-hospital cardiac arrest survivors receiving targeted temperature management. Journal of Critical Care. 40: 36-40. PMID 28314170 DOI: 10.1016/j.jcrc.2017.02.021  0.8
2017 Kim E, Na S, An B, Yang SR, Kim WJ, Ha KS, Han ET, Park WS, Lee CM, Lee JY, Lee SJ, Hong SH. Paracrine influence of human perivascular cells on the proliferation of adenocarcinoma alveolar epithelial cells. The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 21: 161-168. PMID 28280409 DOI: 10.4196/kjpp.2017.21.2.161  0.36
2017 Kim JI, Lee I, Park S, Bae JY, Yoo K, Cheong HJ, Noh JY, Hong KW, Lemey P, Vrancken B, Kim J, Nam M, Yun SH, Cho WI, Song JY, ... Kim WJ, et al. Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea. Plos One. 12: e0172059. PMID 28257427 DOI: 10.1371/journal.pone.0172059  0.32
2017 Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, Joung JG, Nam JY, Ryu D, Yun JW, Choi JK, Ghosh A, Kim KK, Kim SJ, Kim WS, et al. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Oncotarget. PMID 28152507 DOI: 10.18632/oncotarget.14928  0.8
2017 Han YD, Park S, Kim WR, Baek SJ, Hur H, Min BS, Kim NK. Safety and Efficacy of Single-Incision Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair: Comparative Study with Conventional Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. PMID 28129040 DOI: 10.1089/lap.2016.0336  0.32
2017 Hong JY, Ryu KJ, Park C, Hong M, Ko YH, Kim WS, Kim SJ. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Oncotarget. PMID 28099151 DOI: 10.18632/oncotarget.14636  0.8
2016 Kim JH, Kim WS, Hong JY, Ryu KJ, Kim SJ, Park C. Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk. Oncotarget. PMID 28036258 DOI: 10.18632/oncotarget.14243  0.8
2016 Sohn SY, Joo WT, Kim WJ, Kim SJ, Youm Y, Kim HC, Park YR, Lee E. Social network types among older Korean adults: Associations with subjective health. Social Science & Medicine (1982). 173: 88-95. PMID 27936422 DOI: 10.1016/j.socscimed.2016.11.042  0.8
2016 Park HY, Lee SB, Yoo HY, Kim SJ, Kim WS, Kim JI, Ko YH. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. Oncotarget. PMID 27835906 DOI: 10.18632/oncotarget.13239  0.8
2016 Kwon H, Kim WG, Eszlinger M, Paschke R, Song DE, Kim M, Park S, Jeon MJ, Kim TY, Shong YK, Kim WB. Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules. Endocrinology and Metabolism (Seoul, Korea). PMID 27834083 DOI: 10.3803/EnM.2016.31.4.586  0.32
2016 Kim W, Lee HY, Jung SH, Woo MA, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Han J, Jeong JY, Choi JY, Lee KS. Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma. Oncotarget. PMID 27793026 DOI: 10.18632/oncotarget.12920  0.36
2016 Seo S, Hong JY, Yoon S, Yoo C, Park JH, Lee JB, Park CS, Huh J, Lee Y, Kim KW, Ryu JS, Kim SJ, Kim WS, Yoon DH, Suh C. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Oncotarget. PMID 27764777 DOI: 10.18632/oncotarget.12734  0.8
2016 Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, ... ... Kim WS, et al. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget. PMID 27713132 DOI: 10.18632/oncotarget.12459  0.8
2016 Kim MJ, Koo HM, Lee WJ, Choi JH, Choi MN, Park SY, Kim WJ, Son SY. Development of Epidural and Paraspinal Abscesses after Insufficient Evaluation and Treatment of Acute Pyelonephritis Caused by Staphylococcus aureus. Korean Journal of Family Medicine. 37: 299-302. PMID 27688864 DOI: 10.4082/kjfm.2016.37.5.299  0.36
2016 Son SM, Ha SY, Yoo HY, Oh D, Kim SJ, Kim WS, Ko YH. Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27687005 DOI: 10.1038/modpathol.2016.56  0.8
2016 Song HN, Kim SJ, Ko YH, Kim WS. Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma. Acta Haematologica. 136: 186-190. PMID 27623181 DOI: 10.1159/000448159  0.8
2016 Hong JY, Suh C, Kim WS. Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update. F1000research. 5. PMID 27606052 DOI: 10.12688/f1000research.8790.1  0.4
2016 Han KT, Kim W, Kim SJ, Jang SY, Ju YJ, Chun SY, Lee SG, Park EC. Sleep disorders and risk of hospitalization in patients with mood disorders: Analysis of the National Sample Cohort over 10 years. Psychiatry Research. 245: 259-266. PMID 27565697 DOI: 10.1016/j.psychres.2016.08.047  0.36
2016 Yoon DH, Kim SJ, Jeong SH, Shin DY, Bae SH, Hong J, Park SK, Yhim HY, Yang DH, Lee H, Kang HJ, Lee MH, Eom HS, Kwak JY, Lee JH, ... ... Kim WS, et al. Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008). Oncotarget. PMID 27542213 DOI: 10.18632/oncotarget.11319  0.8
2016 Park JH, Woo JS, Ju S, Jung SW, Lee I, Kim JB, Kim SJ, Kim W, Kim WS, Kim KS. Layer-specific analysis of dobutamine stress echocardiography for the evaluation of coronary artery disease. Medicine. 95: e4549. PMID 27512879 DOI: 10.1097/MD.0000000000004549  0.8
2016 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Jung CW. Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation. Oncotarget. PMID 27494893 DOI: 10.18632/oncotarget.10988  0.8
2016 Kim E, Shim HS, Kim WH, Lee SY, Park SK, Yang JH, Jun TG, Kim CS. Predictive Value of Intraoperative Thromboelastometry for the Risk of Perioperative Excessive Blood Loss in Infants and Children Undergoing Congenital Cardiac Surgery: A Retrospective Analysis. Journal of Cardiothoracic and Vascular Anesthesia. PMID 27474337 DOI: 10.1053/j.jvca.2016.03.132  0.36
2016 Jung KS, Cho SH, Kim SJ, Ko YH, Kim WS. Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma. International Journal of Hematology. PMID 27456462 DOI: 10.1007/s12185-016-2068-1  0.8
2016 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. The Journal of Infection. PMID 27394404 DOI: 10.1016/j.jinf.2016.06.011  0.8
2016 Cho I, Kim W, Kim J, Kim HY, Lee H, Kim SJ. Non-Negligible Diffusio-Osmosis Inside an Ion Concentration Polarization Layer. Physical Review Letters. 116: 254501. PMID 27391727 DOI: 10.1103/PhysRevLett.116.254501  0.8
2016 Shin SY, Kim T, Seo DW, Sohn CH, Kim SH, Ryoo SM, Lee YS, Lee JH, Kim WY, Lim KS. Correlation between National Influenza Surveillance Data and Search Queries from Mobile Devices and Desktops in South Korea. Plos One. 11: e0158539. PMID 27391028 DOI: 10.1371/journal.pone.0158539  0.36
2016 Lee WS, Nam GB, Kim SH, Choi JH, Jo U, Kim WY, Oh YS, Park KN, Seo GW, Kim KH, Jin ES, Rhee KS, Jung L, Hwang KW, Kim YR, et al. ECG features and proarrhythmic potentials of therapeutic hypothermia. Heart (British Cardiac Society). PMID 27207979 DOI: 10.1136/heartjnl-2015-308821  0.36
2016 Maeng CH, Ko YH, Lim DH, Kang ES, Choi JY, Kim WS, Kim SJ. Comparison of Total Body Irradiation (TBI) Conditioning with non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T and NK-cell Non-Hodgkin Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27188204 DOI: 10.4143/crt.2015.476  0.8
2016 Jung KS, Cho SH, Kim SJ, Ko YH, Kang ES, Kim WS. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia. Journal of Hematology & Oncology. 9: 41. PMID 27091029 DOI: 10.1186/s13045-016-0271-4  0.8
2016 Shin DY, Kim SJ, Yoon DH, Park Y, Kong JH, Kim JA, Kim BS, Kim HJ, Won JH, Park SK, Kim WS. Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis. Cancer Chemotherapy and Pharmacology. PMID 26984211 DOI: 10.1007/s00280-016-3005-y  0.8
2016 Kim HS, Ryu KJ, Ko YH, Kim HJ, Kim SH, Kim WS, Kim SJ. Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma. Hematological Oncology. PMID 26928433 DOI: 10.1002/hon.2283  0.8
2016 Shin SY, Lee ST, Kim HJ, Oh YL, Kim SJ, Kim WS, Kim SH. Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma. Annals of Laboratory Medicine. 36: 209-14. PMID 26915608 DOI: 10.3343/alm.2016.36.3.209  0.8
2016 Maeng CH, Ahn SW, Ryu SY, Han S, Ko YH, Ji JH, Kim WS, Kim SJ. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy. The Korean Journal of Internal Medicine. PMID 26898595 DOI: 10.3904/kjim.2014.222  0.8
2016 Lim SH, Hyun SH, Kim HS, Lee JY, Yoo KH, Jung KS, Song HN, Cho J, Park S, Ko YH, Kim SJ, Choi JY, Kim WS. Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL. Bone Marrow Transplantation. PMID 26855154 DOI: 10.1038/bmt.2016.6  0.8
2016 Lee SE, Kang SY, Yoo HY, Kim SJ, Kim WS, Ko YH. Clonal relationships in recurrent B-cell lymphomas. Oncotarget. PMID 26848863 DOI: 10.18632/oncotarget.7132  0.8
2016 Yoo HY, Kim P, Kim WS, Lee SH, Kim S, Kang SY, Jang HY, Lee JE, Kim J, Kim SJ, Ko YH, Lee S. Frequent CTLA4-CD28 gene fusion in diverse types of T cell lymphoma. Haematologica. PMID 26819049 DOI: 10.3324/haematol.2015.139253  0.8
2016 Kim JS, Yoon DH, Park S, Yoon SS, Cho SG, Min CK, Lee JJ, Yang DH, Kwak JY, Eom HS, Kim WS, Kim H, Do YR, Moon JH, Lee J, et al. Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study. Annals of Hematology. PMID 26754633 DOI: 10.1007/s00277-016-2589-y  0.32
2016 Kim SM, Park S, Oh DR, Ahn YC, Ko YH, Kim SJ, Kim WS. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability. Annals of Hematology. PMID 26729202 DOI: 10.1007/s00277-015-2581-y  0.8
2015 Kim HK, Moon SM, Moon JH, Park JE, Byeon S, Kim WS. Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin. Blood Research. 50: 254-6. PMID 26770954 DOI: 10.5045/br.2015.50.4.254  0.8
2015 Lee S, Kim MJ, Kim JS, Oh SY, Kim SJ, Kwon YH, Chung IY, Kang JH, Yang DH, Kang HJ, Yoon DH, Kim WS, Kim HJ, Suh C. Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study. Blood Research. 50: 242-7. PMID 26770952 DOI: 10.5045/br.2015.50.4.242  0.8
2015 Kim JH, Kim WS, Ryu K, Kim SJ, Park C. CD79B limits response of diffuse large B cell lymphoma to ibrutinib. Leukemia & Lymphoma. 1-10. PMID 26699656 DOI: 10.3109/10428194.2015.1113276  0.8
2015 Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS, et al. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. The Lancet. Haematology. 2: e66-74. PMID 26687611 DOI: 10.1016/S2352-3026(15)00002-2  0.8
2015 Park S, Jung CW, Kim K, Kim SJ, Kim WS, Jang JH. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients. Oncotarget. PMID 26517509 DOI: 10.18632/oncotarget.5658  0.8
2015 Kim HS, Lee HW, Kim WS, Ko YH. Systemic Epstein-Barr virus-negative mature natural killer-cell lymphoma with cutaneous and visceral involvement. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 123: 990-2. PMID 26495897 DOI: 10.1111/apm.12458  0.8
2015 Lee MY, Kim HS, Lee JY, Lim SH, Kang ES, Ko YH, Kim SJ, Kim WS. Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B-cell lymphoma with secondary central nervous system involvement. International Journal of Hematology. PMID 26493833 DOI: 10.1007/s12185-015-1874-1  0.8
2015 Oh D, Ahn YC, Kim SJ, Kim WS, Ko YH. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. International Journal of Radiation Oncology, Biology, Physics. 93: 677-83. PMID 26461010 DOI: 10.1016/j.ijrobp.2015.07.2267  0.8
2015 Lim SH, Park S, Jang JH, Kim K, Kim HJ, Kim SH, Kang CI, Chung DR, Peck KR, Lee J, Cha HS, Koh EM, Ko YH, Kim WS, Jung CW, et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis. Annals of Hematology. PMID 26453074 DOI: 10.1007/s00277-015-2523-8  0.8
2015 Kim SJ, Ryu KJ, Hong M, Ko YH, Kim WS. Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients. Journal of Hematology & Oncology. 8: 112. PMID 26449540 DOI: 10.1186/s13045-015-0200-y  0.8
2015 Oh SY, Kim WS, Kim JS, Chae YS, Lee GW, Eom HS, Ryoo HM, Lee S, Kim SJ, Yoon DH, Won JH, Hong J, Park J, Lee SM, Hong JY, et al. A phase II study of Oxaliplatin and Prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & Lymphoma. 1-23. PMID 26413982 DOI: 10.3109/10428194.2015.1099650  0.8
2015 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Kang ES, Jung CW. KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study. Human Immunology. PMID 26407827 DOI: 10.1016/j.humimm.2015.09.009  0.8
2015 Lee SH, Kim JS, Kim J, Kim SJ, Kim WS, Lee S, Ko YH, Yoo HY. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients. Haematologica. PMID 26405154 DOI: 10.3324/haematol.2015.133074  0.8
2015 Hong JY, Ko YH, Kim SJ, Kim WS. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update. Current Opinion in Oncology. 27: 392-8. PMID 26258272 DOI: 10.1097/CCO.0000000000000210  0.8
2015 Koh MS, Kim WS, Kim SJ, Oh SY, Yoon DH, Lee SI, Hong J, Song MK, Shin HJ, Kwon JH, Kim HJ, Do YR, Suh C, Kim HJ. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study. International Journal of Hematology. PMID 26210384 DOI: 10.1007/s12185-015-1845-6  0.8
2015 Venkatakrishnan K, Kim TM, Lin CC, Thye LS, Chng WJ, Ma B, Chen MH, Zhou X, Liu H, Kelly V, Kim WS. Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose. Investigational New Drugs. 33: 942-53. PMID 26084989 DOI: 10.1007/s10637-015-0258-y  0.8
2015 Cho HJ, Jang MS, Hong SD, Kim SJ, Ahn YC, Oh D, Ko YH, Kim HY, Dhong HJ, Chung SK, Kim WS. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type. International Forum of Allergy & Rhinology. PMID 26039707 DOI: 10.1002/alr.21564  0.8
2015 Lee S, Park HY, Kang SY, Kim SJ, Hwang J, Lee S, Kwak SH, Park KS, Yoo HY, Kim WS, Kim JI, Ko YH. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type. Oncotarget. PMID 25980440  0.8
2015 Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y, Jo JC, Kim SJ, Yoon DH, Cheong JW, Kwak JY, Lee JJ, Kim WS, Suh C, Yang DH, et al. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25963920 DOI: 10.1016/j.bbmt.2015.05.003  0.8
2015 Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 25832927 DOI: 10.1111/liv.12838  0.8
2015 Yoon H, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH. Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma. Genes, Chromosomes & Cancer. 54: 383-96. PMID 25832818 DOI: 10.1002/gcc.22249  0.8
2015 Lim SH, Woo SY, Kim S, Ko YH, Kim WS, Kim SJ. Cross-sectional Study of Patients with Diffuse Large B-cell lymphoma: Assessing the Effect of Host Status, Tumor Burden and Inflammatory Activity on Venous Thromboembolism. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25761485 DOI: 10.4143/crt.2014.266  0.8
2015 Noh JH, Lee MH, Kim WS, Lim do H, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochirurgica. 157: 569-76. PMID 25663100 DOI: 10.1007/s00701-015-2344-5  0.8
2015 Park S, Kang CI, Chung DR, Peck KR, Kim WS, Kim SJ. Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 448-57. PMID 25648098 DOI: 10.4143/crt.2014.034  0.8
2015 Kim MJ, Hong ME, Maeng CH, Jung HA, Hong JY, Choi MK, Kim SJ, Ko YH, Kim WS. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. International Journal of Hematology. 101: 273-8. PMID 25552248 DOI: 10.1007/s12185-014-1728-2  0.8
2015 Hong J, Kim SJ, Ahn JS, Song MK, Kim YR, Lee HS, Yhim HY, Yoon DH, Kim MK, Oh SY, Park Y, Mun YC, Do YR, Ryoo HM, Lee JJ, ... ... Kim WS, et al. Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 173-81. PMID 25544581 DOI: 10.4143/crt.2014.055  0.8
2015 Tateishi U, Tatsumi M, Terauchi T, Ando K, Niitsu N, Kim WS, Suh C, Ogura M, Tobinai K. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma. Cancer Science. 106: 186-93. PMID 25495273 DOI: 10.1111/cas.12588  0.8
2015 Kim SJ, Hong M, Do IG, Lee SH, Ryu KJ, Yoo HY, Hong JY, Ko YH, Kim WS. Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator. Haematologica. 100: e106-9. PMID 25480498 DOI: 10.3324/haematol.2014.116087  0.8
2015 Yoo KH, Lee JY, Lim SH, Ko YH, Kim SJ, Kim WS. Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphoma. Acta Haematologica. 133: 179-82. PMID 25323539 DOI: 10.1159/000362149  0.8
2015 Jung SH, Lee JJ, Kim WS, Lee WS, Do YR, Oh SY, Kim MK, Mun YC, Shin HJ, Kwak JY, Kang HJ, Won JH, Kwon JH, Park E, Suh C, et al. Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL). European Journal of Haematology. 94: 504-10. PMID 25288018 DOI: 10.1111/ejh.12459  0.8
2015 Kim SJ, Park S, Kang ES, Choi JY, Lim do H, Ko YH, Kim WS. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients. Annals of Hematology. 94: 71-8. PMID 25082384 DOI: 10.1007/s00277-014-2171-4  0.8
2015 Kim SJ, Ryu KJ, Hong M, Ko YH, Kim WS. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients Journal of Hematology and Oncology. DOI: 10.1186/s13045-015-0142-4  0.8
2015 Tan D, Phipps C, Hwang WYK, Tan SY, Yeap CH, Chan YH, Tay K, Lim ST, Lee YS, Kumar SG, Ng SC, Fadilah S, Kim WS, Goh YT. Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicentre phase 2 trial The Lancet Haematology. DOI: 10.1016/S2352-3026(15)00097-6  0.8
2015 Park BB, Kim WS, Suh C, Shin DY, Kim JA, Kim HG, Lee WS. Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial Annals of Hematology. DOI: 10.1007/s00277-015-2468-y  0.8
2014 Yang QM, Hong JY, Ko YH, Lin SY, Au WY, Choi MK, Park S, Kim SJ, Kim WS. Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia. Oncotargets and Therapy. 7: 1717-22. PMID 25328405 DOI: 10.2147/OTT.S67380  0.8
2014 Lee KH, Jung SK, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW, Kim DW, Kang ES. Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience. Vox Sanguinis. 107: 407-15. PMID 25130876 DOI: 10.1111/vox.12183  0.8
2014 Kim SM, Kim MJ, Jung HA, Kim K, Kim SJ, Jang JH, Kim WS, Jung CW. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma. Biomed Research International. 2014: 437852. PMID 25114902 DOI: 10.1155/2014/437852  0.8
2014 Kim SH, Kim IR, Kim SH, Lee S, Ok O, Kim WS, Suh C, Lee MH. Health-related quality of life in Korean lymphoma survivors compared with the general population. Annals of Hematology. 93: 1531-40. PMID 24947794 DOI: 10.1007/s00277-014-2091-3  0.36
2014 Lee SJ, Suh CW, Lee SI, Kim WS, Lee WS, Kim HJ, Choi CW, Kim JS, Shin HJ. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study. The Korean Journal of Internal Medicine. 29: 352-60. PMID 24851070 DOI: 10.3904/kjim.2014.29.3.352  0.8
2014 Kang BW, Sohn SK, Moon JH, Chae YS, Kim JG, Lee SJ, Kim WS, Lee JJ, Lee SR, Park KU, Lee HS, Lee WS, Won JH, Park MR, Kwak JY, et al. Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma. Blood Research. 49: 15-21. PMID 24724062 DOI: 10.5045/br.2014.49.1.15  0.8
2014 Ogura M, Ando K, Suzuki T, Ishizawa K, Oh SY, Itoh K, Yamamoto K, Au WY, Tien HF, Matsuno Y, Terauchi T, Yamamoto K, Mori M, Tanaka Y, Shimamoto T, ... ... Kim WS, et al. A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. British Journal of Haematology. 165: 768-76. PMID 24617454 DOI: 10.1111/bjh.12819  0.8
2014 Kim Y, Ju H, Kim DH, Yoo HY, Kim SJ, Kim WS, Ko YH. CD79B and MYD88 mutations in diffuse large B-cell lymphoma. Human Pathology. 45: 556-64. PMID 24444466 DOI: 10.1016/j.humpath.2013.10.023  0.8
2014 Jung HA, Cho SH, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K. Spinal cord compression in multiple myeloma: a single center experience. Leukemia & Lymphoma. 55: 2395-7. PMID 24397613 DOI: 10.3109/10428194.2014.880429  0.8
2014 Park S, Lee SJ, Jung CW, Jang JH, Kim SJ, Kim WS, Kim K. DCEP for relapsed or refractory multiple myeloma after therapy with novel agents. Annals of Hematology. 93: 99-105. PMID 24240976 DOI: 10.1007/s00277-013-1952-5  0.8
2014 Kim YS, Ji JH, Ko YH, Kim SJ, Kim WS. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP. Acta Haematologica. 131: 156-61. PMID 24192382 DOI: 10.1159/000353787  0.8
2014 Kim SJ, Sohn I, Do IG, Jung SH, Ko YH, Yoo HY, Paik S, Kim WS. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay. Annals of Hematology. 93: 437-47. PMID 23975159 DOI: 10.1007/s00277-013-1884-0  0.8
2014 Ha JM, Kim E, Lee WJ, Hwang JW, Yune S, Ko YH, Choi JY, Kim SJ, Kim WS. Unusual manifestation of intravascular large B-cell lymphoma: Severe hypercalcemia with parathyroid hormone-related protein Cancer Research and Treatment. 46: 307-311. DOI: 10.4143/crt.2014.46.3.307  0.8
2013 Kim SJ, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, ... ... Kim WS, et al. Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group. Journal of Hematology & Oncology. 6: 86. PMID 24238138 DOI: 10.1186/1756-8722-6-86  0.8
2013 Kim SW, Lim do H, Ahn YC, Kim WS, Kim SJ, Ko YH, Kim KM. Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. World Journal of Gastroenterology. 19: 6062-8. PMID 24106407 DOI: 10.3748/wjg.v19.i36.6062  0.8
2013 Kim SJ, Kang HJ, Kim JS, Eom HS, Huh J, Ko YH, Lee J, Yim DS, Lee SY, Park WS, Yang WI, Lee SS, Suh C, Kim WS. A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas. Investigational New Drugs. 31: 1514-21. PMID 23975510 DOI: 10.1007/s10637-013-0015-z  0.8
2013 Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, ... ... Kim WS, et al. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group. European Journal of Cancer (Oxford, England : 1990). 49: 3486-96. PMID 23910494 DOI: 10.1016/j.ejca.2013.07.006  0.8
2013 Choi MK, Kang ES, Kim DW, Ko YH, Seok H, Park JH, Pyo DH, Hoon Lim D, Kim SJ, Kim WS. Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation. International Journal of Hematology. 98: 346-54. PMID 23868695 DOI: 10.1007/s12185-013-1403-z  0.8
2013 Yi HG, Kim JS, Suh C, Kim WS, Kwak JY, Lee JS, Kim YS, Joo YD, Min YH, Lee HG, Yoon SS, Won JH, Park S, Kim HC, Kim CS. Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry. Blood Research. 48: 115-20. PMID 23826580 DOI: 10.5045/br.2013.48.2.115  0.8
2013 Kim SJ, Yoon DH, Yang DH, Eom HS, Cho SG, Yoon SS, Lee JH, Kim WS, Suh C. Plerixafor use for peripheral blood stem cell mobilization in Korea. Blood Research. 48: 72-3. PMID 23826573 DOI: 10.5045/br.2013.48.2.72  0.8
2013 Ha SY, Sung J, Ju H, Karube K, Kim SJ, Kim WS, Seto M, Ko YH. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Pathology, Research and Practice. 209: 448-54. PMID 23735590 DOI: 10.1016/j.prp.2013.04.013  0.8
2013 Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, Park H. EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood. Korean Journal of Pathology. 47: 137-47. PMID 23667373 DOI: 10.4132/KoreanJPathol.2013.47.2.137  0.8
2013 Ohmachi K, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, et al. Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2103-9. PMID 23650408 DOI: 10.1200/JCO.2012.46.5203  0.8
2013 Jang MA, Yoo EH, Kim K, Kim WS, Jung CW, Kim SH, Kim HJ. Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior. International Journal of Hematology. 97: 403-8. PMID 23400412 DOI: 10.1007/s12185-013-1286-z  0.8
2013 Kang HJ, Lee SS, Byun BH, Kim KM, Lim I, Choi CW, Suh C, Kim WS, Nam SH, Lee SI, Eom HS, Shin DY, Lim SM. Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma. Cancer Chemotherapy and Pharmacology. 71: 945-53. PMID 23370662 DOI: 10.1007/s00280-013-2087-z  0.8
2013 Huh HJ, Lee SH, Yoo KH, Sung KW, Koo HH, Jang JH, Kim K, Kim SJ, Kim WS, Jung CW, Lee KO, Kim SH, Kim HJ. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia. Annals of Hematology. 92: 635-44. PMID 23354995 DOI: 10.1007/s00277-012-1664-2  0.8
2013 Lee GY, Kim WS, Ko YH, Choi JO, Jeon ES. Primary cardiac lymphoma mimicking infiltrative cardiomyopathy. European Journal of Heart Failure. 15: 589-91. PMID 23248217 DOI: 10.1093/eurjhf/hfs193  0.8
2013 Ahn HK, Kim SJ, Hwang DW, Ko YH, Tang T, Lim ST, Kim WS. Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma. Investigational New Drugs. 31: 469-72. PMID 23108598 DOI: 10.1007/s10637-012-9889-4  0.8
2012 Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Lee SI, Kang HJ, Choi CW, Park J, Song MK, Kim HJ, Kwon JH, Kwak JY, Bae SH, et al. Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL). International Journal of Hematology. 96: 631-7. PMID 23065471 DOI: 10.1007/s12185-012-1200-0  0.8
2012 Kim SJ, Yoon DH, Kang HJ, Kim JS, Park SK, Kim HJ, Lee J, Ryoo BY, Ko YH, Huh J, Yang WI, Kim HK, Min SK, Lee SS, Do IG, ... ... Kim WS, et al. Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial. European Journal of Cancer (Oxford, England : 1990). 48: 3223-31. PMID 22770877 DOI: 10.1016/j.ejca.2012.06.003  0.8
2012 Park S, Moon SH, Park LC, Hwang DW, Ji JH, Maeng CH, Cho SH, Ahn HK, Lee JY, Kim SJ, Choi JY, Kim WS. The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma. American Journal of Hematology. 87: 937-40. PMID 22730093 DOI: 10.1002/ajh.23267  0.8
2012 Park LC, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population. Thrombosis Research. 130: e6-12. PMID 22507288 DOI: 10.1016/j.thromres.2012.03.019  0.8
2012 Shin EJ, Shin HM, Nam E, Kim WS, Kim JH, Oh BH, Yun Y. DeSUMOylating isopeptidase: a second class of SUMO protease. Embo Reports. 13: 339-46. PMID 22370726 DOI: 10.1038/embor.2012.3  0.8
2012 Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leukemia & Lymphoma. 53: 1515-24. PMID 22273250 DOI: 10.3109/10428194.2012.659735  0.8
2012 Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Kang HJ, Song MK, Kim HJ, Kwon JH, Kwak JY, Park BB, Do YR, Jeong SH, Suh C. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study. Acta Haematologica. 127: 100-4. PMID 22178776 DOI: 10.1159/000333113  0.8
2012 Na YJ, Kim ER, Kim SJ, Kim WS, Ko YH, Son HJ. Primary gastrointestinal follicular lymphoma: single-center 12-year experiences. Hepato-Gastroenterology. 59: 751-3. PMID 22020908 DOI: 10.5754/hge11569  0.8
2012 Kang HJ, Kim WS, Kim SJ, Lee JJ, Yang DH, Kim JS, Lee SR, Lee GW, Kim HJ, Kim HY, Oh SY, Kim HC, Eom HS, Chung J, Park J, et al. Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study Annals of Hematology. 91: 543-551. PMID 21922208 DOI: 10.1007/s00277-011-1337-6  0.8
2012 Yhim HY, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy. International Journal of Cancer. Journal International Du Cancer. 131: 235-43. PMID 21823120 DOI: 10.1002/ijc.26352  0.8
2012 Lee HY, Kim SJ, Kim K, Ko YH, Kim WS. Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value? Leukemia & Lymphoma. 53: 173-5. PMID 21812537 DOI: 10.3109/10428194.2011.608452  0.8
2012 Won YW, Kwon JH, Lee SI, Oh SY, Kim WS, Kim SJ, Won JH, Kim KH, Park SK, Kim JS, Suh C, Yoon DH, Park JS, Kim MK, Kim H, et al. Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL). Annals of Hematology. 91: 223-33. PMID 21789622 DOI: 10.1007/s00277-011-1297-x  0.8
2012 Kim SJ, Kim K, Park Y, Kim BS, Huh J, Ko YH, Park K, Suh C, Kim WS. Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity. Investigational New Drugs. 30: 368-75. PMID 20734108 DOI: 10.1007/s10637-010-9523-2  0.8
2011 Choi SY, Kim SJ, Kim WS, Kim K, Ko YH. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis. Virchows Archiv : An International Journal of Pathology. 459: 495-502. PMID 22002677 DOI: 10.1007/s00428-011-1153-3  0.8
2011 Kim YR, Kim JS, Kim SJ, Jung HA, Kim SJ, Kim WS, Lee HW, Eom HS, Jeong SH, Park JS, Cheong JW, Min YH. Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. Journal of Hematology & Oncology. 4: 34. PMID 21843362 DOI: 10.1186/1756-8722-4-34  0.8
2011 Kim SJ, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, Won JH, Kim MK, Kwon JH, Kim JS, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Lee JH, ... ... Kim WS, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). Bmc Cancer. 11: 321. PMID 21798075 DOI: 10.1186/1471-2407-11-321  0.8
2011 Park S, Kim K, Kim DH, Jang JH, Kim SJ, Kim WS, Jung CW, Koh KC. Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1630-7. PMID 21565276 DOI: 10.1016/j.bbmt.2011.04.006  0.8
2011 Lim T, Kim SJ, Kim K, Lee JI, Lim do H, Lee DJ, Baek KK, Lee HY, Han B, Uhm JE, Ko YH, Kim WS. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Annals of Hematology. 90: 1391-8. PMID 21479535 DOI: 10.1007/s00277-011-1225-0  0.8
2011 Kim JW, Kim BS, Bang SM, Kim I, Kim DH, Kim WS, Yang DH, Lee JJ, Lee JH, Kim JS, Sohn SK, Yhim HY, Kwak JY, Yoon SS, Lee JS, et al. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation. Annals of Hematology. 90: 1409-18. PMID 21468694 DOI: 10.1007/s00277-011-1227-y  0.32
2011 Won YW, Yi SY, Jang JH, Kim K, Kim SJ, Kim WS, Jung CW, Kim DH. Retrospective analysis of paranasal sinusitis in patients receiving hematopoietic stem cell transplantation. International Journal of Hematology. 93: 383-8. PMID 21360008 DOI: 10.1007/s12185-011-0797-8  0.8
2011 Kim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, ... ... Kim WS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 117: 1958-65. PMID 21148334 DOI: 10.1182/blood-2010-06-288480  0.8
2011 Sung CO, Kim SC, Karnan S, Karube K, Shin HJ, Nam DH, Suh YL, Kim SH, Kim JY, Kim SJ, Kim WS, Seto M, Ko YH. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma Blood. 117: 1291-1300. PMID 21088137 DOI: 10.1182/blood-2010-07-297861  0.8
2011 Yi JH, Kim SJ, Ko YH, Kim WS. Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy. Leukemia & Lymphoma. 52: 317-20. PMID 21067447 DOI: 10.3109/10428194.2010.529203  0.8
2011 Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C. Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma. Annals of Hematology. 90: 539-46. PMID 20960190 DOI: 10.1007/s00277-010-1104-0  0.8
2010 Jin J, Joo KM, Nam Y, Kim DH, Lee SJ, Jo MY, Jin Y, Kim HS, Seo SW, Kim SJ, Nam DH, Kim WS. Schedule-dependent synergistic effect of rituximab on methotrexate chemotherapy against lymphoma of the central nervous system. Experimental and Therapeutic Medicine. 1: 943-946. PMID 22993623 DOI: 10.3892/etm.2010.143  0.8
2010 Kim SJ, Kim WS. Treatment of localized extranodal NK/T cell lymphoma, nasal type International Journal of Hematology. 92: 690-696. PMID 21086194 DOI: 10.1007/s12185-010-0720-8  0.8
2010 Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, et al. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study. International Journal of Hematology. 92: 510-7. PMID 20838958 DOI: 10.1007/s12185-010-0680-z  0.8
2010 Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, et al. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study. Cancer Science. 101: 2443-7. PMID 20831770 DOI: 10.1111/j.1349-7006.2010.01698.x  0.8
2010 Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. Bmc Cancer. 10: 321. PMID 20569446 DOI: 10.1186/1471-2407-10-321  0.8
2010 Kim ST, Lee MH, Kim SY, Kim SJ, Kim DH, Jang JH, Kim K, Kim WS, Jung CW. A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 91: 886-91. PMID 20454943 DOI: 10.1007/s12185-010-0580-2  0.8
2010 Won YW, Kim SJ, Kim K, Ko YH, Kim WS. Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea. Annals of Hematology. 89: 1011-8. PMID 20449747 DOI: 10.1007/s00277-010-0978-1  0.8
2010 Ko YH, Karnan S, Kim KM, Park CK, Kang ES, Kim YH, Kang WK, Kim SJ, Kim WS, Lee WY, Chun HK, Seto M. Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study. Human Pathology. 41: 1231-7. PMID 20399483 DOI: 10.1016/j.humpath.2009.11.020  0.8
2010 Yun J, Kim SJ, Won JH, Choi CW, Eom HS, Kim JS, Kim MK, Kwak JY, Kim WS, Suh C. Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report. Leukemia Research. 34: 1175-9. PMID 20206997 DOI: 10.1016/j.leukres.2010.02.010  0.8
2010 Ahn HK, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS. Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients. International Journal of Hematology. 91: 456-63. PMID 20198460 DOI: 10.1007/s12185-010-0536-6  0.8
2010 Park S, Bahng S, Kim EK, Park SB, Sung YK, Kim SJ, Kim WS, Ko YH. Hodgkin's lymphoma arising in a patient with hypersensitivity to mosquito bites: a case report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: e148-50. PMID 20065183 DOI: 10.1200/JCO.2009.25.0357  0.8
2010 Oh SY, Kim WS, Kim JS, Kim SJ, Kwon HC, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Lee GW, Choi CW, Park J, et al. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Annals of Hematology. 89: 563-8. PMID 20024551 DOI: 10.1007/s00277-009-0875-7  0.8
2010 Yun J, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, Ko YH, Kim WS. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience. Acta Haematologica. 123: 48-54. PMID 19955711 DOI: 10.1159/000262291  0.8
2010 Kim HS, Kim WS, Park SH, Jung CW, Choi HY, Lee HM, Jeon SS, Ha H, Hwang IG, Lee S, Lim HY. Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapy. Urologic Oncology. 28: 157-63. PMID 18976937 DOI: 10.1016/j.urolonc.2008.08.002  0.8
2010 Roh JH, Kim SJ, Kim WS, Ko YH. The prognostic subgroups as defined by the patterns of Epstein-Barr virus infection in patients with Hodgkin lymphoma Korean Journal of Pathology. 44: 22-27. DOI: 10.4132/KoreanJPathol.2010.44.1.22  0.8
2009 Oh SY, Kim WS, Kim SJ, Kim JS, Kim SH, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Kim JG, Yang DH, Kang HJ, Choi CW, Park J, et al. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases. American Journal of Hematology. 84: 826-9. PMID 19890833 DOI: 10.1002/ajh.21557  0.8
2009 Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, ... Kim WS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6027-32. PMID 19884539 DOI: 10.1200/JCO.2009.23.8592  0.8
2009 Chang MH, Kim SJ, Kim K, Oh SY, Lee DH, Huh J, Ko YH, Choi CW, Yang DH, Won JH, Kim WS, Suh C. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea. Leukemia & Lymphoma. 50: 1119-25. PMID 19557632 DOI: 10.1080/10428190902926999  0.8
2009 Uhm JE, Kim KH, Yi SY, Chang MH, Park KW, Kong DS, Lee JI, Nam do H, Park W, Lim do H, Kim SJ, Kim K, Ko YH, Kim WS. A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma. Leukemia & Lymphoma. 50: 1110-8. PMID 19557631 DOI: 10.1080/10428190902964776  0.8
2009 Kim HS, Kim KH, Kim KH, Chang MH, Ji SH, Lim do H, Kim K, Kim SJ, Ko Y, Ki CS, Jo SJ, Lee JW, Kim WS. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leukemia & Lymphoma. 50: 757-63. PMID 19330658 DOI: 10.1080/10428190902803669  0.8
2009 Choi MK, Jun HJ, Lee SY, Kim KH, Lim do H, Kim K, Ko YH, Kim WS, Kim SJ. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Annals of Hematology. 88: 1099-106. PMID 19288103 DOI: 10.1007/s00277-009-0729-3  0.8
2009 Park CH, Kimler BF, Yi SY, Park SH, Kim K, Jung CW, Kim SH, Lee ER, Rha M, Kim S, Park MH, Lee SJ, Park HK, Lee MH, Yoon SS, ... ... Kim WS, et al. Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes. European Journal of Haematology. 83: 108-18. PMID 19284416 DOI: 10.1111/j.1600-0609.2009.01252.x  0.8
2009 Hwang YC, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocrine Journal. 56: 399-405. PMID 19225216 DOI: 10.1507/endocrj.K08E-355  0.8
2009 Choi KA, Lee JE, Kim YG, Kim DJ, Kim K, Ko YH, Oh HY, Kim WS, Huh W. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Annals of Hematology. 88: 639-45. PMID 19030857 DOI: 10.1007/s00277-008-0642-1  0.4
2009 Sym SJ, Lee DH, Kang HJ, Nam SH, Kim HY, Kim SJ, Eom HS, Kim WS, Suh C. A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma. Cancer Chemotherapy and Pharmacology. 64: 27-33. PMID 18839172 DOI: 10.1007/s00280-008-0847-y  0.8
2009 Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh SJ, Jang JH, Kim K, Jung CW, Ahn YC, Park K, Ko YH, Kim WS. Clinical features and prognostic factors of patients with "peripheral T cell lymphoma, unspecified". Annals of Hematology. 88: 111-9. PMID 18648812 DOI: 10.1007/s00277-008-0544-2  0.4
2009 Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS. Rituximab-induced acute thrombocytopenia: A case report and review of the literature Medical Oncology. 26: 45-48. DOI: 10.1007/s12032-008-9079-6  0.8
2008 Ko YH, Park S, Kim K, Kim SJ, Kim WS. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? Acta Haematologica. 120: 199-206. PMID 19153474 DOI: 10.1159/000193225  0.8
2008 Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, Kameoka J, Sakai C, Oshimi K, Kwong YL, Liang R, Yiu H, Wong KH, Cheng HC, Ryoo BY, Suh C, ... ... Kim WS, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1356-64. PMID 19041057 DOI: 10.1016/j.bbmt.2008.09.014  0.4
2008 Kim JH, Kim WS, Park C. SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death Leukemia and Lymphoma. 49: 1392-1398. PMID 18452098 DOI: 10.1080/10428190802087454  0.8
2007 Kim JG, Sohn SK, Chae YS, Yang DH, Lee JJ, Kim HJ, Shin HJ, Jung JS, Kim WS, Kim DH, Suh C, Kim SJ, Eom HS, Bae SH. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplantation. 40: 919-24. PMID 17846602 DOI: 10.1038/sj.bmt.1705841  0.8
2007 Park BB, Kim JG, Sohn SK, Kang HJ, Lee SS, Eom HS, Kwon HC, Oh SY, Kang JH, Oh SJ, Shin HJ, Suh C, Kim JH, Kim HY, Kim K, ... ... Kim WS, et al. Consideration of aggressive therapeutic strategies for primary testicular lymphoma. American Journal of Hematology. 82: 840-5. PMID 17563078 DOI: 10.1002/ajh.20973  0.36
2007 Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, ... ... Kim WS, et al. Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leukemia & Lymphoma. 48: 716-22. PMID 17454629 DOI: 10.1080/10428190601123989  0.4
2007 Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 110: 972-8. PMID 17400912 DOI: 10.1182/blood-2007-01-067769  0.4
2007 Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 463-8. PMID 17382252 DOI: 10.1016/j.bbmt.2006.11.019  0.8
2007 Oh SY, Ryoo BY, Kim WS, Park YH, Kim K, Kim HJ, Kwon JM, Lee J, Ko YH, Ahn YC, Oh SJ, Lee SI, Kim HJ, Kwon HC, Bang SM, et al. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases. American Journal of Hematology. 82: 446-52. PMID 17266060 DOI: 10.1002/ajh.20874  0.4
2007 Lee J, Kim WS, Kim K, Ahn JS, Jung CW, Lim HY, Kang WK, Park K, Ko YH, Kim YH, Park C, Yoon SH, Lee WY, Chun HK. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leukemia Research. 31: 359-64. PMID 16930692 DOI: 10.1016/j.leukres.2006.06.018  0.4
2006 Park YH, Kim WS, Bang SM, Lee SI, Uhm JE, Kang HJ, Na II, Yang SH, Lee SS, Kim K, Jung CW, Park K, Ko YH, Ryoo BY. Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphoma. European Journal of Haematology. 77: 304-8. PMID 16879609 DOI: 10.1111/j.1600-0609.2006.00709.x  0.4
2006 Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, ... ... Kim WS, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 612-8. PMID 16380410 DOI: 10.1200/JCO.2005.04.1384  0.4
2005 Park BB, Kim WS, Lee J, Park KW, Kang JH, Lee SH, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Ko YH, Lee MH, Park K. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas. Leukemia & Lymphoma. 46: 1743-8. PMID 16263576 DOI: 10.1080/10428190500178266  0.8
2005 Lee J, Lee MH, Park KW, Kang JH, Im DH, Kim K, Lee SH, Kim WS, Park J, Jung CW, Parka K. Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission. International Journal of Hematology. 81: 258-63. PMID 15814338 DOI: 10.1532/IJH97.A30411  0.8
2005 Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 122-8. PMID 15682073 DOI: 10.1016/j.bbmt.2004.11.018  0.8
2004 Park SH, Kang WK, Lee HR, Park J, Lee KE, Lee SH, Park JO, Kim K, Kim WS, Chung CW, Im YH, Lee MH, Park CH, Park K. Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. American Journal of Clinical Oncology. 27: 477-80. PMID 15596914 DOI: 10.1097/01.coc.0000136018.81814.79  0.8
2004 Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K, Han JH, et al. Primary pulmonary non-Hodgkin's lymphoma. Japanese Journal of Clinical Oncology. 34: 510-4. PMID 15466823 DOI: 10.1093/jjco/hyh095  0.8
2004 Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Joh J, Kim K, Jung CW, Park YS, Im YH, et al. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 54: 385-90. PMID 15248028 DOI: 10.1007/s00280-004-0837-7  0.8
2004 Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, Chun HK, Lee WY, Park JO, Jung CW, Im YH, Lee MH, Kang WK, Park K. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leukemia & Lymphoma. 45: 339-44. PMID 15101721 DOI: 10.1080/10428190310001593111  0.8
2004 Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, et al. Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer. Oncology. 66: 32-7. PMID 15031596 DOI: 10.1159/000076332  0.8
2004 Lee J, Lee MH, Kim WS, Kim K, Park SH, Lee SH, Lee KE, Park J, Park JO, Jung CW, Im YH, Kang WK, Park K. Tuberculosis in hematopoietic stem cell transplant recipients in Korea. International Journal of Hematology. 79: 185-8. PMID 15005349 DOI: 10.1532/IJH97.A10219  0.8
2004 Park SH, Lee MH, Lee SH, Lee KE, Park J, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K, Kim SW, Lee KH, Lee JH. The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation Journal of Korean Medical Science. 19: 79-82. PMID 14966346 DOI: 10.3346/jkms.2004.19.1.79  0.8
2003 Lee SH, Ahn YC, Kim HJ, Lim DH, Lee SI, Nam E, Park SH, Park J, Lee KE, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, et al. Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancer. Japanese Journal of Clinical Oncology. 33: 620-5. PMID 14769839 DOI: 10.1093/jjco/hyg115  0.8
2003 Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K. Measuring response in solid tumors: Comparison of RECIST and WHO response criteria Japanese Journal of Clinical Oncology. 33: 533-537. PMID 14623923 DOI: 10.1093/jjco/hyg093  0.8
2002 Kim K, Lee MH, Kim J, Lee KS, Kim SM, Jung MP, Han J, Sung KW, Kim WS, Jung CW, Yoon SS, Im YH, Kang WK, Park K, Park CH. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. American Journal of Hematology. 71: 75-9. PMID 12353303 DOI: 10.1002/ajh.10168  0.8
2002 Kim K, Nam E, Lee NS, Lee HR, Lee JY, Lee HR, Park SH, Oh SY, Kim JH, Song SY, Park JO, Kim WS, Jung CW, Im YH, Lee MH, et al. Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer. American Journal of Clinical Oncology. 25: 354-7. PMID 12151964 DOI: 10.1097/00000421-200208000-00007  0.8
2002 Park SH, Lee MH, Lee H, Kim HS, Kim K, Kim WS, Jung CW, Im YH, Yoon SS, Kang WK, Park K, Park CH, Kim SW. A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation Bone Marrow Transplantation. 29: 137-143. PMID 11850708 DOI: 10.1038/sj/bmt/1703342  0.8
2002 Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, Park CH, Ko YH, Ree HJ, Park K. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification European Journal of Cancer. 38: 75-81. PMID 11750843 DOI: 10.1016/S0959-8049(01)00344-6  0.8
2001 Kim WS, Kim MM, Choi HJ, Yoon SS, Lee MH, Park K, Park CH, Kang WK. Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma Investigational New Drugs. 19: 81-83. PMID 11291836 DOI: 10.1023/A:1006481423298  0.8
Show low-probability matches.